Ashley Hall
Corporate Officer/Principal bei RENEO PHARMACEUTICALS, INC.
Vermögen: 65 736 $ am 31.03.2024
Profil
Ashley F.
Hall is currently the Chief Development Officer at Reneo Pharmaceuticals, Inc. She previously worked as the Director of World Wide Regulatory Affairs at Medimmune, Inc. from 2007 to 2009, Vice President of Regulatory Affairs at CancerVax Corp., Vice President of Regulatory Affairs at Amgen Rockville, Inc. from 2010 to 2012, Vice President of Regulatory and Clinical Affairs at Revogenex Ltd., and Chief Development Officer at Esperion Therapeutics, Inc. from 2019 to 2021.
Ms. Hall received her undergraduate degree from the University of California San Diego and her graduate degree from the University of San Diego School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.08.2023 | 39 600 ( 0,12% ) | 65 736 $ | 31.03.2024 |
Aktive Positionen von Ashley Hall
| Unternehmen | Position | Beginn |
|---|---|---|
| RENEO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 11.10.2021 |
Ehemalige bekannte Positionen von Ashley Hall
| Unternehmen | Position | Ende |
|---|---|---|
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | General Counsel | 01.05.2012 |
| Medimmune, Inc. | General Counsel | 01.08.2009 |
| CancerVax Corp. | General Counsel | - |
Revogenex Ltd.
 Revogenex Ltd. Pharmaceuticals: MajorHealth Technology Revogenex Ltd. is an American company that manufactures pharmaceutical products. | Chief Tech/Sci/R&D Officer | - |
| ESPERION THERAPEUTICS, INC. | General Counsel | - |
Ausbildung von Ashley Hall
| University of California San Diego | Undergraduate Degree |
| University of San Diego School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| RENEO PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| CancerVax Corp. | Commercial Services |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
| Medimmune, Inc. | Health Technology |
Revogenex Ltd.
Revogenex Ltd. Pharmaceuticals: MajorHealth Technology Revogenex Ltd. is an American company that manufactures pharmaceutical products. | Health Technology |
